BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33649832)

  • 41. TMED3 stabilizes SMAD2 by counteracting NEDD4-mediated ubiquitination to promote ovarian cancer.
    Chen X; Zhang W; Han X; Li X; Xia L; Wu Y; Zhou Y
    Mol Carcinog; 2024 May; 63(5):803-816. PubMed ID: 38411267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
    Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
    BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NIT1 suppresses tumour proliferation by activating the TGFβ1-Smad2/3 signalling pathway in colorectal cancer.
    Lin C; Zhang J; Lu Y; Li X; Zhang W; Zhang W; Lin W; Zheng L; Li X
    Cell Death Dis; 2018 Feb; 9(3):263. PubMed ID: 29449642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angelica sinensis polysaccharide suppresses the Wnt/β-catenin-mediated malignant biological behaviors of breast cancer cells via the miR-3187-3p/PCDH10 axis.
    Cai Y; Wang Y; Su W; Zhou X; Lu C
    Biochem Pharmacol; 2024 Jul; 225():116295. PubMed ID: 38762145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silence of TPPP3 suppresses cell proliferation, invasion and migration via inactivating NF-κB/COX2 signal pathway in breast cancer cell.
    Ren Q; Hou Y; Li X; Fan X
    Cell Biochem Funct; 2020 Aug; 38(6):773-781. PubMed ID: 32515139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11.
    Chen Y; Tang W; Zhu X; Zhang L; Zhu Y; Xiao H; Xu J; Fang Y; Li X; Tang C; Shi J
    Bioengineered; 2021 Dec; 12(2):11506-11519. PubMed ID: 34905470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Downregulation of TBC1 Domain Family Member 24 (BC1D24) Inhibits Breast Carcinoma Growth via IGF1R/PI3K/AKT Pathway.
    Qu X; Zhao B; Hu M; Ji Z; Xu J; Xia W; Qu Y
    Med Sci Monit; 2018 Jun; 24():3987-3996. PubMed ID: 29893377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway.
    Gong W; Sun B; Zhao X; Zhang D; Sun J; Liu T; Gu Q; Dong X; Liu F; Wang Y; Lin X; Li Y
    Oncotarget; 2016 Oct; 7(43):70152-70167. PubMed ID: 27659524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
    Yang YH; Deng H; Li WM; Zhang QY; Hu XT; Xiao B; Zhu HH; Geng PL; Lu YY
    Clin Cancer Res; 2008 Jan; 14(1):74-81. PubMed ID: 18172255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.
    Guo J; Canaff L; Rajadurai CV; Fils-Aimé N; Tian J; Dai M; Korah J; Villatoro M; Park M; Ali S; Lebrun JJ
    Breast Cancer Res; 2014 Dec; 16(6):476. PubMed ID: 25499443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
    Qin T; Li B; Feng X; Fan S; Liu L; Liu D; Mao J; Lu Y; Yang J; Yu X; Zhang Q; Zhang J; Song B; Li M; Li L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):287. PubMed ID: 30482232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
    Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
    Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
    Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
    Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis.
    Zhang L; Sun D; Zhang J; Tian Y
    Life Sci; 2021 Feb; 266():118829. PubMed ID: 33259864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch.
    Dali-Youcef N; Hnia K; Blaise S; Messaddeq N; Blanc S; Postic C; Valet P; Tomasetto C; Rio MC
    Sci Rep; 2016 Apr; 6():25140. PubMed ID: 27126782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Signaling via Smad2 and Smad3 is dispensable for adult murine hematopoietic stem cell function in vivo.
    Billing M; Rörby E; Dahl M; Blank U; Andradottír S; Ehinger M; Karlsson S
    Exp Hematol; 2017 Nov; 55():34-44.e2. PubMed ID: 28666967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer.
    Gao S; Ge A; Xu S; You Z; Ning S; Zhao Y; Pang D
    J Exp Clin Cancer Res; 2017 Dec; 36(1):179. PubMed ID: 29216929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
    Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P
    Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1.
    Ungefroren H; Groth S; Sebens S; Lehnert H; Gieseler F; Fändrich F
    Mol Cancer; 2011 May; 10():67. PubMed ID: 21624123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway.
    Wang HB; Wei H; Wang JS; Li L; Chen AY; Li ZG
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):708-723. PubMed ID: 30611858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.